RAINBOW CHILDREN'S MEDICARE Q2 FY27 ; NET PROFIT UP 11% AT ₹84 CR (YOY), UP 34% (QOQ)

REVENUE UP 23% AT ₹548 CR (YOY), UP 17% (QOQ) EBITDA UP 14% AT ₹170 CR (YOY), UP 26% (QOQ) MARGINS AT 31.0% VS 33.5% (YOY), 28.6% (QOQ)

RAINBOW CHILDRENS MED LTD